Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30352784

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Dec 13
First author
Bahlis NJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Bahlis NJ
      type
      Author
    2. name
      Sutherland H
      type
      Author
    3. name
      White D
      type
      Author
    4. name
      Sebag M
      type
      Author
    5. name
      Lentzsch S
      type
      Author
    6. name
      Kotb R
      type
      Author
    7. name
      Venner CP
      type
      Author
    8. name
      Gasparetto C
      type
      Author
    9. name
      Del Col A
      type
      Author
    10. name
      Neri P
      type
      Author
    11. name
      Reece D
      type
      Author
    12. name
      Kauffman M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Bahlis NJ
      type
      Author
    2. name
      Sutherland H
      type
      Author
    3. name
      White D
      type
      Author
    4. name
      Sebag M
      type
      Author
    5. name
      Lentzsch S
      type
      Author
    6. name
      Kotb R
      type
      Author
    7. name
      Venner CP
      type
      Author
    8. name
      Gasparetto C
      type
      Author
    9. name
      Del Col A
      type
      Author
    10. name
      Neri P
      type
      Author
    11. name
      Reece D
      type
      Author
    12. name
      Kauffman M
      type
      Author
    bibliography ids
    1. nci-bib-0846119b6ca8642ff92583a8
    book metadata
    content sha256
    431219b484dcabb37fb0ec290ef6760f719e399bc23ab663612af035c4af98e8
    document type
    citation
    dois
    1. 10.1182/blood-2018-06-858852
    electronic publication date
    display
    2018 Oct 23
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30352784
    immutable id
    pubmed:30352784@431219b484dcabb37fb0ec290ef6760f719e399bc23ab663612af035c4af98e8
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    24
    name
    Blood
    nlm unique id
    7603509
    pages
    2546-2554
    volume
    132
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30352784
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      43543561c608cd3bf46fc0f6c21862ff4e256856ced57732902c6d3cd7aced4d
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Dec 13
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30352784/
      title
      Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma.

      Preserved source evidence · Not medical advice